Sep 302016
Talent4Boards - Great Talent builds Great Boards
– USA, MA – Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that Mark J.… => Read more
Chiasma appoints Mark Fitzpatrick to its Board of Directors as CEO
From:: Chiasma appoints Mark Fitzpatrick to its Board of Directors as CEO
Sorry, the comment form is closed at this time.